New York, US – December 30, 2019 – Delhi, India experiences severe air-pollution recently. It is no more a news, but the same story of spiking air pollution.
According to the World Health Organization (WHO), Delhi’s air quality has already been rated as one of the most hazardous. India is ranked fifth most polluted country in the world after Bangladesh, Egypt, the United Arab Emirates (UAE) and Mongolia.
According to the GLOBOCAN 2012 report, the estimated incidence of lung cancer in India was 70,275 in all ages and both sexes; the crude incidence rate per 100,000 was 5.6, the age-standardized rate per 100,000 (world). Non-small lung cancer accounts for 85 per cent of the cases.
Tagrisso price is more than 4000USD per month, which is almost impossible to afford for 95% of the people in India. And also the state insurance never pays for it.
Tagrix (Osimertinib) is the only generic kinase inhibitor indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC) in the world. But due to the patent problem, this item only for one of the poorest country in the world.
As one of the poorest country in the World, Bangladesh 48.3% of men smoke tobacco. With tobacco being one of the most important modifiable cancer risk factors, Bangladesh has implemented an action plan for tobacco control. Tagrisso cost in Bangladesh is not a problem because there are two listed companies that have the authority to produce generic osimertinib. Tagrisso side effects is controlled for both brand and generic one.
Prevention is better than cure. Therefore, we can take little steps towards a better health care, especially during the most polluted months of the year.